A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study

Westhovens, Rene;Durez, Patrick;Devogelaer, Jean-Pierre;Van den Bosch, F.;Vastesaeger, N.;et.al.
(2004) Annual European Congress of Rheumatology (EULAR 2004) — Location: Berlin (Germany) (9.June.2004)

Files

No attached file found for this publication.

Details

Authors
  • Westhovens, ReneUCLouvain
    Author
  • Author
  • Devogelaer, Jean-PierreUCLouvain
    Author
  • Van den Bosch, F.
    Author
  • Veys, EmilieUCLouvain
    Author
  • Vastesaeger, N.
    Author
Show more
Affiliations

Citations

Westhovens, R., Durez, P., Devogelaer, J.-P., Van den Bosch, F., Corluy, L., Veys, E., De Clerck, L., Peretz, A., Malaise, M., & Vastesaeger, N. (2004). A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study. Annals of the Rheumatic Diseases, 63, 90. https://hdl.handle.net/2078.5/64942 (Original work published 2004)